BridgeBio Oncology Therapeutics, Inc. (BBOT)

Profile

Full Name

BridgeBio Oncology Therapeutics, Inc.

Ticker

NASDAQ: BBOT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 12, 2025

Indexes

Not included

Website

https://bbotx.com

Employees

62

Key Details

Price

$8.94(-5.40%)

Market cap

$708.02M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$0.94(-14.81% YoY)

PE ratio

-

Next earnings date

Nov 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.94
    BBOT price is $8.94

    30-Day Relative Volume

    1.62
    BBOT 30-day relative volume is 1.62

    Price Performance

    Price Today change

    -5.4%
    BBOT price is down -5.4% today

    Price YTD change

    -14.86%
    BBOT price is down -14.86% since January 1st

    Price 1-year change

    -13.29%
    BBOT price is down -13.29% year-on-year

    Price 3-year change

    -
    BBOT price 3-year change is unknown

    Price Range

    Price All-time high

    $12.50
    BBOT price is currently -28.48% below its historical high of $12.50

    Price 3-year low

    $8.50
    BBOT price is currently +5.18% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $708.02M
    BBOT market capitalization is $708.02 million

    Market cap 3-year change

    -
    BBOT market capitalization 3-year change is unknown

    Market cap All-time high

    $956.70M
    BBOT market capitalization is currently -25.99% below its historical high of $956.70 million

    Market cap sector rank

    69.24%
    BBOT market capitalization is higher than 69.24% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    BBOT shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    BBOT shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.01
    BBOT beta is -0.01

    200-day SMA

    $10.64
    BBOT price is currently -15.96% below its 200-day simple moving average

    50-day SMA

    $10.36
    BBOT price is currently -13.73% below its 50-day simple moving average

    RSI

    44.57
    BBOT 14-day relative strength index is 44.57

    Volume

    1.62
    BBOT 30-day relative volume is 1.62

    ATR

    $0.89
    BBOT average true range is $0.89

    10-day Historical Volatility

    137.89%
    BBOT 10-day historical volatility is 137.89%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BBOT annual revenue is $0.00

    Revenue Analysts estimate

    -
    BBOT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    BBOT annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.67%
    BBOT annual revenue is higher than 28.67% of companies in Healthcare sector

    EPS

    EPS

    -$0.94
    BBOT annual earnings per share is -$0.94

    EPS Analysts estimate

    -
    BBOT annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -14.81%
    BBOT annual earnings per share is down -14.81% year-on-year

    EPS Sector rank

    53.41%
    BBOT annual earnings per share is higher than 53.41% of companies in Healthcare sector

    Profit

    Gross profit

    -
    BBOT annual gross profit value is unknown

    Gross margin

    -
    BBOT annual gross profit margin value is unknown

    Operating profit

    -$80.86M
    BBOT annual operating income is -$80.86 million

    Operating margin

    -
    BBOT annual operating profit margin value is unknown

    Net income

    -$74.28M
    BBOT annual net profit is -$74.28 million

    Net margin

    -
    BBOT annual net profit margin value is unknown

    Expenses

    Total expenses

    $80.86M
    BBOT annual total expenses is $80.86 million

    Operating expenses

    $80.86M
    BBOT annual total operating expenses is $80.86 million

    Cost of goods sold

    -
    BBOT annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $7.76M
    BBOT annual SGA is $7.76 million

    Depreciation and amortization

    $208.00K
    BBOT annual depreciation & amortization is $208.00 thousand

    Interest expense

    -
    BBOT annual interest expense value is unknown

    Income tax

    -
    BBOT annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$80.86M
    BBOT annual earnings before interest & taxes is -$80.86 million

    EBITDA

    -$80.66M
    BBOT annual EBITDA is -$80.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $164.30M
    BBOT annual total assets is $164.30 million

    Non current assets

    $5.61M
    BBOT annual long term assets is $5.61 million

    Current assets

    $158.69M
    BBOT annual total current assets is $158.69 million

    Cash and cash equivalents

    $30.85M
    BBOT annual cash & cash equivalents is $30.85 million

    Accounts receivable

    -
    BBOT annual accounts receivable value is unknown

    Inventory

    -
    BBOT annual inventory value is unknown

    Liabilities

    Total liabilities

    $342.94M
    BBOT annual total liabilities is $342.94 million

    Long term liabilities

    $323.36M
    BBOT annual total long term liabilities is $323.36 million

    Current liabilities

    $19.58M
    BBOT annual total current liabilities is $19.58 million

    Accounts payable

    $3.07M
    BBOT annual accounts payable is $3.07 million

    Debt

    Total debt

    -
    BBOT annual total debt value is unknown

    Total debt 1-year change

    -
    BBOT annual total debt 1-year change is unknown

    Long term debt

    -
    BBOT annual long term debt value is unknown

    Short term debt

    -
    BBOT annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    -$178.64M
    BBOT annual stockholders equity is -$178.64 million

    Book value

    -$178.64M
    BBOT annual book value is -$178.64 million

    Retained earnings

    -$222.52M
    BBOT annual retained earnings is -$222.52 million

    Working capital

    $139.11M
    BBOT annual working capital is $139.11 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$55.03M
    BBOT annual cash flow from operations is -$55.03 million

    Cash from operations 1-year change

    -5.66%
    BBOT annual cash flow from operations is down -5.66% year-on-year

    Cash from investing

    -$120.53M
    BBOT annual cash flow from investing activities is -$120.53 million

    Cash from investing 1-year change

    -4174.11%
    BBOT annual cash flow from investing activities is down -4174.11% year-on-year

    Cash from financing

    $206.29M
    BBOT annual cash flow from financing activities is $206.29 million

    Cash from financing 1-year change

    +274.23%
    BBOT annual cash flow from financing activities is up +274.23% year-on-year

    CAPEX

    CAPEX

    $49.00K
    BBOT annual capital expenditures is $49.00 thousand

    CAPEX 1-year change

    -88.16%
    BBOT annual capital expenditures is down -88.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$55.08M
    BBOT annual free cash flow is -$55.08 million

    Free cash flow 1-year change

    -4.92%
    BBOT annual free cash flow is down -4.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BBOT annual gross profit margin value is unknown

    Operating margin

    -
    BBOT annual operating profit margin value is unknown

    Net margin

    -
    BBOT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.21%
    BBOT annual return on assets is -45.21%

    ROE

    41.58%
    BBOT annual return on equity is 41.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BBOT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BBOT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.74
    BBOT price to book ratio is 3.74

    PB ratio Sector rank

    71.99%
    BBOT price to book ratio is higher than 71.99% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BBOT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BBOT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $707.35M
    BBOT enterprise value is $707.35 million

    Enterprise value Sector rank

    70.81%
    BBOT enterprise value is higher than 70.81% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -29.22
    BBOT EV/EBITDA is -29.22

    EV/EBITDA Sector rank

    4.77%
    BBOT EV/EBITDA is higher than 4.77% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.10
    BBOT annual current ratio is 8.10

    Quick ratio

    -
    BBOT annual quick ratio value is unknown

    Leverage

    Debt to equity

    -
    BBOT annual debt to equity ratio value is unknown

    Interest coverage ratio

    -
    BBOT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BBOT piotroski f-score value is unknown

    Altman Z-Score

    -1.27
    BBOT altman z-score is -1.27

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with BBOT included

    US stocks
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    Stocks with low beta
    • What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc.?
    • Does BridgeBio Oncology Therapeutics, Inc. pay dividends?
    • What sector is BridgeBio Oncology Therapeutics, Inc. in?
    • What industry is BridgeBio Oncology Therapeutics, Inc. in?
    • What country is BridgeBio Oncology Therapeutics, Inc. based in?
    • When did BridgeBio Oncology Therapeutics, Inc. go public?
    • Is BridgeBio Oncology Therapeutics, Inc. in the S&P 500?
    • Is BridgeBio Oncology Therapeutics, Inc. in the NASDAQ 100?
    • Is BridgeBio Oncology Therapeutics, Inc. in the Dow Jones?
    • When was BridgeBio Oncology Therapeutics, Inc.'s last earnings report?
    • When does BridgeBio Oncology Therapeutics, Inc. report earnings?

    What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc.?

    The ticker symbol for BridgeBio Oncology Therapeutics, Inc. is NASDAQ:BBOT

    Does BridgeBio Oncology Therapeutics, Inc. pay dividends?

    No, BridgeBio Oncology Therapeutics, Inc. does not pay dividends

    What sector is BridgeBio Oncology Therapeutics, Inc. in?

    BridgeBio Oncology Therapeutics, Inc. is in the Healthcare sector

    What industry is BridgeBio Oncology Therapeutics, Inc. in?

    BridgeBio Oncology Therapeutics, Inc. is in the Biotechnology industry

    What country is BridgeBio Oncology Therapeutics, Inc. based in?

    BridgeBio Oncology Therapeutics, Inc. is headquartered in United States

    When did BridgeBio Oncology Therapeutics, Inc. go public?

    BridgeBio Oncology Therapeutics, Inc.'s initial public offering (IPO) was on August 12, 2025

    Is BridgeBio Oncology Therapeutics, Inc. in the S&P 500?

    No, BridgeBio Oncology Therapeutics, Inc. is not included in the S&P 500 index

    Is BridgeBio Oncology Therapeutics, Inc. in the NASDAQ 100?

    No, BridgeBio Oncology Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is BridgeBio Oncology Therapeutics, Inc. in the Dow Jones?

    No, BridgeBio Oncology Therapeutics, Inc. is not included in the Dow Jones index

    When was BridgeBio Oncology Therapeutics, Inc.'s last earnings report?

    BridgeBio Oncology Therapeutics, Inc.'s most recent earnings report was on August 5, 2025

    When does BridgeBio Oncology Therapeutics, Inc. report earnings?

    The next expected earnings date for BridgeBio Oncology Therapeutics, Inc. is November 28, 2025
    On this page